CARA - Cara Therapeutics EPS beats by $0.12 beats on revenue August, 10 2020 04:06 PM Cara Therapeutics Inc. Cara Therapeutics (NASDAQ:CARA): Q2 GAAP EPS of -$0.54 beats by $0.12.Revenue of $5.63M (+8.3% Y/Y) beats by $0.57M.Press ReleaseMore news on: Cara Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news,